News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sundance Diagnostics Announces it Will Target Risk of Suicide and Risk of Violence in Development of its Genetic Tests to Curb Prescription Drug Side Effects


3/12/2013 9:22:59 AM

BOULDER, Colo.--(BUSINESS WIRE)--Sundance Diagnostics, Inc., a Boulder, CO diagnostics development company, announced today that it will focus on risk of suicide and the potential risk of acts of violence in development of its genetic tests designed to curb prescription drug side effects. The first test to be developed is for the risk of medication-induced suicidal thinking and behavior—a known serious side effect of antidepressant drugs. Following that, Sundance plans to investigate genetic markers for risk of medication-induced acts of violence—a potential prescription drug side effect.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES